Anika Therapeutics named Stephen R. Mascioli, MD, MPH, CMO, and Dana M. Alexander COO.
Here are four points:
1. Dr. Mascioli has more than 25 years of leadership experience, and he previously held the inaugural CMO position at Terumo Americas Holdings.
2. He has also served as CMO of the vascular therapies division of Covidien.
3. Mr. Alexander has more than 20 years of operational expertise in manufacturing and supply chain management.
4. He most recently served in various leadership roles at Genzyme, most recently heading Genzyme's flagship biologics plant.